DARPA to develop novel therapeutics for multi-drug resistant microbial infections
Washington DC (SPX) Aug 06, 2021 DARPA has selected three performer teams to support the Harnessing Enzymatic Activity for Lifesaving Remedies (HEALR) program. Groups from Yale University, University of Washington, and Broad Institute plan to utilize a new therapeutic approach and novel protein degradation strategies/modalities to permit a flexible and rapid response for targeting emerging microbial threats. These researchttp://dlvr.it/S5RS5y Continue reading DARPA to develop novel therapeutics for multi-drug resistant microbial infections

